Supersapiens Gives Athletes Visibility Into Glucose, Redefines Fueling in Sport


In partnership with Abbott, the new ecosystem is available now in select European Markets

ATLANTA, Dec. 10, 2020 (GLOBE NEWSWIRE) -- For any human, proper glucose management can mean the difference between feeling good or feeling lackluster. For athletes, the stakes are even higher: Dial in your optimal fuel intake and you can feel strong, fast, and agile in athletic situations. On the other hand, get it wrong -- eat too much of the wrong thing or too little of the right thing -- and your body could rebel, leaving you out of energy and out of the competition -- a worst-case scenario.

Supersapiens, utilizing the Abbott Libre Sense Glucose Sport Biosensor, is the first over-the-counter energy management ecosystem that can give any athlete real-time visibility into their glucose levels, allowing them to fine-tune fueling strategies before, during, and after training and racing. This advancement in sports science stands to eliminate a major variable from race preparation and execution, helping athletes feel more confident on the start line, and ensuring that they have continuous guidance on how to fuel during an event.

Supersapiens Founder and CEO Phil Southerland said “I’ve been an athlete for as long as I can remember and through my own obsession with training and racing, I learned that I was a stronger, faster, better version of myself when I kept my glucose within my optimal range. At the same time, when it went outside of my optimal range, I couldn’t perform at the same level. Getting to bring this same knowledge, to the general athletic population is a dream come true. Everyone’s minds are about to be illuminated by the correlation between proper glucose management and sustained peak performance.”

The Supersapiens ecosystem is powered by and includes the Abbott Libre Sense Sport Biosensor, the Supersapiens App, and a reader that displays data from the biosensor in real-time. The app tracks glucose data in real-time and allows athletes to create events -- workouts, meals, rest -- so they can see how various glucose levels impact racing and training. The app’s Learn Hub features educational information that helps athletes better understand glucose and the impact it has on performance and learn how to optimize fueling strategies for sustained performance in a variety of sporting events.

CE marked in September, Supersapiens is quickly becoming a must-have piece of training technology for athletes at the highest level of sport. Team Jumbo-Visma, the INEOS Grenadiers, and Canyon//SRAM pro tour teams are all finding success with Supersapiens, including the INEOS Grenadiers’ win at the Giro d’Italia and Team Jumbo-Visma’s second consecutive win at the Vuelta a España after training with the ecosystem. The BMC-Vifit Pro Triathlon Team is the first top-level multi-sport team to track their glucose during training and racing.

The impact and benefits of glucose on endurance sports have been researched and understood for some time but real-time glucose visibility is only now available to athletes through the Abbott Libre Sense Glucose Sport Biosensor. Through a partnership with global healthcare leader Abbott, Supersapiens is able to make this key new performance metric available to athletes looking to improve their performance through glucose visibility.

The science behind Supersapiens has been evaluated and supported by some of the world’s leading sport and performance researchers, including Asker Jeukendrup (PhD), former head of the Gatorade Sports Science Lab, as well as leading endocrinological and performance researchers Juan Pablo Frias (MD), Chief Science Officer, and Federico Fontana (PhD), Vice President for Scientific Affairs.

The Supersapiens Ecosystem and the Abbott Libre Sense Glucose Sport Biosensor is available now in select European markets at

About Supersapiens
Supersapiens is an Atlanta-based sports technology company focused on energy management systems to empower sustained peak performance. Supersapiens empowers athletes to show up to the starting line optimally fueled, manage in-race fueling to sustain peak performance, and guide refueling and recovery.

The Abbott Libre Sense Glucose Sport Biosensor is intended for athletes to measure glucose. Athletes are defined as individuals who perform exercise with the purpose of improving wellness and performance. When used with a compatible product, the biosensor allows athletes to correlate their glucose levels and their athletic performance. The biosensor is not intended for use in the diagnosis, treatment, or monitoring of a disease.The Supersapiens ecosystem, including the Abbott Libre Sense Glucose Sport System, is not available for sale in the U.S.

Contact Info:
Fitzalan Crowe

A photo accompanying this announcement is available at

About GlobeNewswire

One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

Talenom Plc will publish its Financial Statements Bulletin for 2020 on 8 February 2021 at 13:30 EET25.1.2021 11:00:00 CETPress release

Talenom Plc, Press release 25 January 2021 at 12:00 EET Talenom Plc will publish its Financial Statements Bulletin for 2020 on 8 February 2021 at 13:30 EET Talenom Plc will publish its Financial Statements Bulletin for 2020 on Monday 8 February 2021 at 13:30 EET. The company’s CEO Otto-Pekka Huhtala will present the highlights of the release for analysts, investors and media in Finnish, followed by CFO Antti Aho’s presentation in English as a live webcast on Monday 8 February 2021 at 14:00 EET. The webcast can be viewed online at Participants will have the opportunity to present questions during the briefing over the webcast platform. The presentation materials will be published before the start of the briefing on the company’s website at TALENOM PLC Further information: Otto-Pekka Huhtala CEO, Talenom Plc +358 40 703 8554 Talenom is an agile and progressive accounting firm established

SEK CREDIT OPERATION ANNOUNCEMENT25.1.2021 10:30:00 CETPress release

Bid date, 2021-01-25Auction date2021-01-25Settlement date2021-01-25Maturity Date2021-04-26Term13 weeksInterest rateThe Riksbank´s applicable repo rateBid times11.00-11.30 (CET/CEST) on the Bid dateConfirmation of bids to e-maileol@riksbank.seOffered volumeUnlimitedThe lowest accepted bid volume50 million SEKMaximum number of bids1Allocation Time11.45 (CET/CEST) on the Bid date Stockholm, 2021-01-25 Bid date, 2021-01-25Auction date2021-01-25Settlement date2021-01-25Maturity Date2021-07-26Term26 weeksInterest rateThe Riksbank´s applicable repo rateBid times11.00-11.30 (CET/CEST) on the Bid dateConfirmation of bids to e-maileol@riksbank.seOffered volumeUnlimitedThe lowest accepted bid volume50 million SEKMaximum number of bids1Allocation Time11.45 (CET/CEST) on the Bid date Stockholm, 2021-01-25 This is a translation of the Swedish version published on In the case of any inconsistency between the English translation and the Swedish language version, the Swedish language v

Scandinavian Tobacco Group A/S: Transactions in connection with share buy-back programme25.1.2021 09:53:20 CETPress release

Company Announcement No. 4/2021 Copenhagen, 25 January 2021 Transactions in connection with share buy-back programme On 28 August 2020, Scandinavian Tobacco Group A/S (“STG”) announced that a share buy-back programme of an aggregated price of up to DKK 300 million was launched with the purpose to adjust the Company’s capital structure and meet obligations relating to the Group’s share-based incentive programme. The buy-back programme is executed in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (the “Market Abuse Regulation”) and Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour rules. The share buy-back programme will end no later than 26 February 2021. The following transactions have been executed from 18 January to 22 January 2021: Number of sharesAverage purchase price, DKKTransaction value, DKKAccumulated, last announcement2,288,034223,181,64219 January 202122,000112.562,476,27819 January 202122,00

Scandinavian Tobacco Group A/S: Transaktioner i forbindelse med aktietilbagekøbsprogram25.1.2021 09:53:20 CETpressemeddelelse

Selskabsmeddelelse Nr. 4/2021 København, 25. januar 2021 Transaktioner i forbindelse med aktietilbagekøbsprogram Den 28. august 2020 informerede Scandinavian Tobacco Group A/S (“STG”) om iværksættelsen af et aktietilbagekøbsprogram til en samlet pris på op til DKK 300 millioner med det formål at justere selskabets kapitalstruktur og opfylde forpligtelserne i forhold til koncernens aktiebaserede incitamentsprogram. Aktietilbagekøbsprogrammet vil blive gennemført i overensstemmelse med EU-forordning nr. 596/2014 af 16. april 2014 (Markedsmisbrugsforordningen) og Kommissionens delegerede forordning (EU) 2016/1052, de såkaldte Safe Harbour-regler. Aktietilbagekøbsprogrammet slutter senest den 26. februar 2021. Følgende transaktioner er foretaget i perioden 18. januar – 22. januar 2021: Antal aktierGennemsnitlig købspris, DKKTransaktionsværdi, DKKTotal, seneste opgørelse2.288.034223.181.64218. januar 202122.000112,562.476.27819. januar 202122.000112,492.474.85320. januar 202121.130112,742.3